Seer (SEER) EBITDA Margin (2020 - 2026)
Seer (SEER) recorded quarterly EBITDA Margin of 621.55% in Q1 2026, down 63.54% quarter-over-quarter from 380.05% in Q4 2025, and down 15119.0% on a YoY basis from N/an in Q1 2025.
Seer (SEER) EBITDA Margin (2020 - 2026) Analysis & Trends
Seer's EBITDA Margin history runs 7 years deep, the most recent figure standing at 621.55% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 15119.0% year-over-year to 621.55%; the TTM figure through Mar 2026 stood at 467.22% (up 8829.0% YoY), while the FY2025 annual figure was 442.01%, up 16681.0% from the prior year.
- EBITDA Margin was 621.55% for Q1 2026 at Seer, down from 380.05% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 376.18% in Q4 2023 to a low of 765.01% in Q1 2022.
- Historically, EBITDA Margin has averaged 553.55% across 5 years, with a median of 559.88% in 2024.
- The sharpest annual moves came in 2022 and 2024: EBITDA Margin soared 2577532 bps in 2022, then slumped 18369 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 457.83% in 2022, then climbed by 18 bps to 376.18% in 2023, then plunged by 49 bps to 559.88% in 2024, then surged by 32 bps to 380.05% in 2025, then sank by 64 bps to 621.55% in 2026.
- The last three EBITDA Margin figures came in at 621.55% (Q1 2026), 380.05% (Q4 2025), and 439.46% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | -621.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -621.55% |
| Dec 31, 2025 | -380.05% |
| Sep 30, 2025 | -439.46% |
| Jun 30, 2025 | -479.44% |
| Mar 31, 2025 | -470.37% |
| Dec 31, 2024 | -559.88% |
| Sep 30, 2024 | -493.87% |
| Jun 30, 2024 | -747.23% |
| Mar 31, 2024 | -685.19% |
| Dec 31, 2023 | -376.18% |
| Sep 30, 2023 | -501.01% |
| Jun 30, 2023 | -620.51% |
| Mar 31, 2023 | -562.57% |
| Dec 31, 2022 | -457.83% |
| Sep 30, 2022 | -595.70% |
| Jun 30, 2022 | -654.54% |
| Mar 31, 2022 | -765.01% |
| Dec 31, 2021 | -661.02% |
| Sep 30, 2021 | -851.93% |
| Jun 30, 2021 | -1,250.22% |